Table 3.
Clinical Characteristics of Covid-19 Patients on Admission.
| Parameters | All | Males | Females | P-Value |
|---|---|---|---|---|
| N | 300 | 259 | 41 | |
| Complete Blood Count | ||||
| Hemoglobin (g/l) | 13.0 ± 1.8 | 13.1 ± 1.8 | 12.1 ± 1.6 | 0.003 |
| WBC count (4.0–11.0)* | 11.5 ± 1.8 | 11.9 ± 2.1 | 8.7 ± 0.5 | NS |
| Platelet count (140–450)* | 264.8 ± 6.8 | 267.8 ± 7.6 | 246.5 ± 14.9 | NS |
| Lymphocyte (1–5)* | 1.4 ± 0.05 | 1.4 ± 0.06 | 1.4 ± 0.11 | NS |
| D-Dimer (µg/ml) (0.22–0.45)* | 2.7 ± 0.7 | 2.8 ± 0.8 | 1.8 ± 0.3 | NS |
| Liver Profile | ||||
| AST (U/l) (15–37)* | 65.5 ± 4.0 | 66.6 ± 4.3 | 58.6 ± 9.0 | NS |
| ALT (U/l) (20–65)* | 70.8 ± 5.4 | 74.6 ± 6.2 | 45.9 ± 5.5 | 0.006 |
| LDH (U/l) (84–246)* | 474.7 ± 14.9 | 486.4 ± 16.1 | 400.3 ± 36.3 | 0.029 |
| Albumin | 25.1 ± 3.9 | 25.3 ± 4.1 | 24.0 ± 2.7 | NS |
| Bilirubin* | 12.6 ± 0.8 | 12.9 ± 0.9 | 10.5 ± 1.2 | NS |
| Renal Profile | ||||
| Creatinine (µmol/l) (49–90)* | 111.9 ± 6.8 | 111.6 ± 7.0 | 114.0 ± 22.6 | NS |
| Inflammatory Markers | ||||
| Ferritin (µg/ml) (13–150)* | 566.7 ± 25.4 | 594.0 ± 27.7 | 400.4 ± 55.7 | 0.001 |
| CRP (mg/l) (<10.0)* | 136.5 ± 8.0 | 139.6 ± 8.5 | 118.7 ± 22.9 | NS |
| Troponin* | 0.13 ± 0.08 | 0.14 ± 0.09 | 0.10 ± 0.06 | NS |
| Glycemic Profile | ||||
| HbA1c (<6.0)** | 9.0 ± 2.5 | 8.9 ± 2.4 | 9.3 ± 2.9 | NS |
| Random blood glucose | 10.0 ± 5.6 | 10.2 ± 5.6 | 9.3 ± 5.4 | NS |
| Other Markers | ||||
| Calcium | 2.1 ± 0.2 | 2.1 ± 0.2 | 2.0 ± 0.09 | NS |
| Phosphorous | 1.1 ± 0.6 | 1.2 ± 0.6 | 0.9 ± 0.5 | NS |
| Magnesium | 0.9 ± 0.2 | 0.9 ± 0.2 | 0.8 ± 0.1 | NS |
Note: *denotes non-normal data and presented as mean ± standard error; ** Only 67 patients had HbA1c levels assessed on admission; WBC, white blood count; AST, aspartate aminotransferase; ALT, alanine transferase; LDH, lactate dehydrogenase; CRP, C-reactive protein; HbA1c, glycated hemoglobin; NS, not significant; all p-values adjusted for age; significant at p < 0.05.